CL2007002789A1 - CRYSTAL FORM OF [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENCIL] METHYLAMINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AFFECTIVE AND DEPRESSIVE DISORDERS, ANXIETY, PAIN. - Google Patents

CRYSTAL FORM OF [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENCIL] METHYLAMINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AFFECTIVE AND DEPRESSIVE DISORDERS, ANXIETY, PAIN.

Info

Publication number
CL2007002789A1
CL2007002789A1 CL200702789A CL2007002789A CL2007002789A1 CL 2007002789 A1 CL2007002789 A1 CL 2007002789A1 CL 200702789 A CL200702789 A CL 200702789A CL 2007002789 A CL2007002789 A CL 2007002789A CL 2007002789 A1 CL2007002789 A1 CL 2007002789A1
Authority
CL
Chile
Prior art keywords
compound
ilsulfanil
bencil
affective
fluor
Prior art date
Application number
CL200702789A
Other languages
Spanish (es)
Inventor
Jan Juhl Karsten Anders Kehler
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CL2007002789A1 publication Critical patent/CL2007002789A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CL200702789A 2006-09-28 2007-09-27 CRYSTAL FORM OF [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENCIL] METHYLAMINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AFFECTIVE AND DEPRESSIVE DISORDERS, ANXIETY, PAIN. CL2007002789A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200601251 2006-09-28
DKPA200700432 2007-03-20

Publications (1)

Publication Number Publication Date
CL2007002789A1 true CL2007002789A1 (en) 2008-04-18

Family

ID=40225153

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702789A CL2007002789A1 (en) 2006-09-28 2007-09-27 CRYSTAL FORM OF [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENCIL] METHYLAMINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AFFECTIVE AND DEPRESSIVE DISORDERS, ANXIETY, PAIN.

Country Status (8)

Country Link
KR (1) KR20090074749A (en)
AR (1) AR062981A1 (en)
BR (1) BRPI0717038A2 (en)
CL (1) CL2007002789A1 (en)
EA (1) EA200970325A1 (en)
IL (1) IL197720A0 (en)
NO (1) NO20091642L (en)
TW (1) TW200829550A (en)

Also Published As

Publication number Publication date
IL197720A0 (en) 2009-12-24
KR20090074749A (en) 2009-07-07
TW200829550A (en) 2008-07-16
AR062981A1 (en) 2008-12-17
EA200970325A1 (en) 2009-12-30
NO20091642L (en) 2009-04-27
BRPI0717038A2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
CL2007002967A1 (en) CRYSTAL FORM A OF THE COMPOUND 4- [3- (4-CYCLOPROPANCARBONIL-PIPERAZIN-1-CARBONIL) -4-FLUORO-BENCIL] -2H-FTALAZIN-1-ONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF A
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
CL2008000127A1 (en) COMPOUNDS DERIVED FROM N- (HETEROARIL) -1-HETEROARIL-1H-INDOL-2-CARBOXAMIDS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PAIN, INFLAMMATION, UROLOGICAL DISORDERS
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
CL2007002974A1 (en) COMPOUNDS DERIVED FROM BENZOIMIDAZOL; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH DGAT1.
CL2007001902A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A DISORDER OF AGGREGATION OF PLATES.
CL2007002121A1 (en) COMPOUNDS DERIVED FROM PIRAZOLES, GLUCOQUINASA ACTIVATORS; PREPARATION PROCESS OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND USE FOR THE TREATMENT OF DISEASES AND / OR METABOLIC DISORDERS, AS DIAB
CL2008003593A1 (en) Isoxazolo-pyridazine derived compounds; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cognitive disorders such as Alzheimer's
CL2007000806A1 (en) COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2007002207A1 (en) COMPOUNDS DERIVED FROM SULFONYLAMINES; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS IN THE TREATMENT OF GLAUCOMA.
CL2007003389A1 (en) CRYSTAL FORMS OF SALTS OF ZOLEDRONIC ACID; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2007002930A1 (en) A COMPOUND 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROFENOXI] -N-METHYLPIRIDIN-2-CARBONXAMIDE MONOHIDRATADO; PREPARATION PROCESS; COMPOSITION AND PHARMACEUTICAL COMBINATION; AND USE FOR THE TREATMENT OF HYPERPROLIFERATI DISORDERS
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
CL2007002920A1 (en) COMPOUNDS DERIVED FROM 2-AMINOCARBONYLPIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007001630A1 (en) COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C.
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
BRPI0922233A2 (en) compounds, pharmaceutical compositions and methods for use in the treatment of metabolic syndromes.
CL2009000004A1 (en) Crystal form of r-2- (4-cyclopropanesulfonyl-phenyl) -n-pyrazin-2-yl-3- (tetrahydropyran-4-yl) -propionamide; pharmaceutical composition comprising said crystalline form; and use for the treatment of diabetes or hyperglycemia.
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
CL2007003038A1 (en) COMPOUNDS DERIVED FROM 2-PHENYL-6-AMINOCARBONIL-PYRIMIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007003672A1 (en) COMPOUNDS DERIVED FROM HETEROARIL-PIRROLIDINIL-CETONA AND HETEROARIL-PIPERIDINIL-CETONA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION AND ANXIETY.
CL2007000680A1 (en) CRYSTAL COMPOUND (5S) -5- [4 (CHLORINE-PIRIDIN-2-ILOXI) -PIPERIDIN-1-SULPHONYLMETIL] -5-METHYL-IMIDAZOLIDIN-2,4-DIONA, FORM G; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR COPD TREATMENT.
BRPI0720323A2 (en) compound, method of treatment, pharmaceutical composition and use of the compound
BRPI0818267A2 (en) New 1,3-dihydro-5-isobenzofuranocarbonitrile derivatives and their pharmaceutical composition for the treatment of premature ejaculation
BRPI0813587A2 (en) COMPOUND, USE OF THE SAME, AND PHARMACEUTICAL COMPOSITION